levofloxacin has been researched along with Bacterial Infections, Gram-Negative in 108 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (5.56) | 18.2507 |
2000's | 29 (26.85) | 29.6817 |
2010's | 59 (54.63) | 24.3611 |
2020's | 14 (12.96) | 2.80 |
Authors | Studies |
---|---|
Calvet, L; Devine, R; Dubreuil, L; Jean-Pierre, H; Jumas-Bilak, E; Marchandin, H; Mercier, G; Morio, F | 1 |
Baudry, PJ; DeCorby, M; Hoban, DJ; Johnson, J; Karlowsky, JA; Lagacé-Wiens, P; Laing, N; McCracken, M; Mulvey, MR; Nichol, KA; Tailor, F; Vashisht, R; Walkty, A; Weshnoweski, B; Wierzbowski, A; Zhanel, GG | 1 |
Amsler, KM; Bush, K; Davies, TA; Jacobs, MR; Shang, W | 1 |
Hiramatsu, K; Kikuchi, K; Ohtsuka, M; Ono, Y; Sasaki, T; Shimizu, K; Takahashi, N | 1 |
Amicosante, G; De Luca, F; Luzzaro, F; Migliavacca, R; Mugnaioli, C; Pagani, L; Perilli, M; Pini, B; Pollini, S; Rossolini, GM; Spalla, M; Toniolo, A | 1 |
Badal, RE; Bouchillon, SK; Hawser, SP; Hoban, DJ; Hsueh, PR; Paterson, DL | 1 |
El-Sherbeny, EME; Kassem, S; Khoris, EA | 1 |
Li, LH; Lin, YT; Liu, YF; Lu, HF; Yang, TC | 1 |
Assanelli, AA; Bernardi, M; Carletti, S; Carrabba, MG; Castagna, A; Ciceri, F; Clerici, D; Corti, C; Erbella, F; Farina, F; Galli, L; Giglio, F; Greco, R; Liberatore, C; Lorentino, F; Lugli, AP; Lupo Stanghellini, MT; Mancini, N; Mastaglio, S; Nitti, R; Oltolini, C; Peccatori, J; Poli, A; Ripa, M; Ruggeri, A; Scarpellini, P; Tassan Din, C; Xue, E | 1 |
Appaneal, HJ; Caffrey, AR; LaPlante, KL; Lopes, VV | 1 |
Chang, FY; Lai, JJ; Lin, JC; Siu, LK; Wang, CH; Wu, RX; Yu, CM | 1 |
Hsueh, PR; Ko, WC; Lee, YL; Liu, CE | 1 |
Braga, LMPDS; Brandão, MLL; da Costa, LV; de Miranda, RVDSL; Dos Reis, CMF; Dos Santos, MCS; Forsythe, SJ; Monteiro, GM; Villas Bôas, MHS | 1 |
Cherabuddi, K; Klinker, KP; Nys, C; Venugopalan, V | 1 |
Hsu, ST; Wang, CH; Wu, RX; Yu, CM | 2 |
Kanderi, T; Komanduri, S; Mansoora, Q; Shah, K; Shrimanker, I; Yumen, A | 1 |
Barrueto, LRL; Campana, EH; Felix, TP; Mançano, SMCN; Pereira, PS; Picão, RC | 1 |
Duan, Z; Li, C; Liu, Y; Qin, J; Ying, C | 1 |
Araoka, H; Asano-Mori, Y; Ishiwata, K; Kageyama, K; Kaji, D; Kimura, M; Mitsuki, T; Nishida, A; Ogura, S; Takagi, S; Taniguchi, S; Taya, Y; Uchida, N; Wake, A; Yamamoto, G; Yamamoto, H; Yuasa, M | 1 |
Li, J; Li, XN; Zhang, P; Zhang, YZ | 1 |
Hibi, A; Kumano, Y | 1 |
Hadano, Y; Ohkusu, K; Tamagawa, K | 1 |
Gamian, A; Korzeniowska-Kowal, A; Paściak, M; Rogala, K; Zdziarski, P | 1 |
Kishimoto, K; Watari, T | 1 |
Alfonso, EC; Gibbons, A; Miller, D; OʼBrien, TP; Palioura, S; Spierer, O | 1 |
Treadwell, T; Yuan, J | 1 |
Hu, Y; Li, Z; Sun, F; Wang, D; Xu, R | 1 |
Fukushima, H; Hara, H; Harada, T; Hyo, Y | 1 |
Cantón, R; Halperin, A; Hermida, JM; Morosini, MI; Morte, E; Tolmos, M | 1 |
Chen, Y; Cui, Y; Guo, P; Guo, X; Shao, S | 1 |
Dizbay, M; Karamanlıoğlu, D | 1 |
Guertin, C; Nixon, CP; Sweeney, JD | 1 |
Limova, M; North, J; Tartar, D | 1 |
Cho, SY; Chung, DR; Ha, YE; Kang, CI; Kim, J; Lee, NY; Peck, KR; Song, JH | 1 |
Chang, SW; Chen, PR; Kuo, HY; Liou, ML; Liu, CC; Pien, CJ; Yeh, HW | 1 |
Alba, L; Behta, M; Clock, SA; Della-Latta, P; Furuya, EY; Jenkins, SG; Jia, H; Kubin, CJ; Oliveira, AP; Patel, SJ; Rhee, K; Saiman, L; Schuetz, AN; Weisenberg, SA; Whittier, S; Zhou, JJ | 1 |
Daryanani-Daryanani, R; Estevez-Dominguez, R; Gil-Diaz, A; Gil-Reyes, J; Monzon-Moreno, C | 1 |
Baek, JH; Choi, JY; Han, SH; Jeong, SJ; Kim, CO; Kim, JM; Ku, NS; Lee, K; Song, YG; Yong, D | 1 |
Bauters, T; Blot, S; Buyle, F; Claeys, G; Robays, H; Van Landuyt, K; Vanhove, W; Vogelaers, D | 1 |
Correia, CR; Ferreira, ST; Nunes, P | 1 |
Arthur, C; Gossett, JG; Harik, N; Prodhan, P; Romero, JR; Tang, X | 1 |
Andrés, M; Aquilino, A; Galiana, AJ; Gutiérrez, F; López, P; Masiá, M; Tovar, J | 1 |
Butler-Wu, S; Miles-Jay, A; Pergam, SA; Rowhani-Rahbar, A | 1 |
Hawkins, AP; Kirages, D; Sahai-Srivastava, S; Sigman, E; Sum, JC | 1 |
Chen, DS; Hsu, HY; Sand, D; Schur, M; She, R; Shulman, IA | 1 |
Han, XY; Li, L; Tarrand, JJ | 1 |
Eroğlu, C; Günaydın, M; Güney, AK; Karadağ, A; Usta, E; Yanık, K | 1 |
Gautam, V; Kaur, P; Tewari, R | 1 |
Budzik, JF; Dehecq, E; Ducoulombier, V; Houvenagel, E; Pascart, T | 1 |
Darouiche, RO; Steenbergen, J; Umeh, O; Wagenlehner, FM; Yuan, G | 1 |
Chan, JF; Yuen, KY | 1 |
Edwards, JK | 1 |
Cai, X; Cui, J; Ni, W; Wei, C | 1 |
Batlle Massana, M; Fernandez Sojo, J; Morgades, M; Quesada, MD; Ribera Santasusana, JM; Vives Polo, S | 1 |
Berghofen, A; Krämer, BK; Krüger, B; Mircheva, M; Popa, C | 1 |
Boyles, T | 1 |
Kielstein, JT; Schmidt, JJ | 1 |
Darouiche, RO; Umeh, O; Wagenlehner, FM | 1 |
Beaudoin, T; LiPuma, JJ; Tom, SK; Waters, V; Yau, YC | 1 |
Iván, M; Juhász, E; Kristóf, K; Pongrácz, J | 1 |
Chang, SJ; Hsieh, CH; Yang, SS | 1 |
Bessa, MC; Ferreira, CA; Figueiredo, TP; Gallo, SW; Oliveira, SD; Pagnussatti, VE | 1 |
Chang, FY; Chang, PY; Chao, TY; Chen, YC; Dai, MS; Ho, CL; Kao, WY; Lin, JC; Wang, CH; Wu, YY | 1 |
Crocetta, V; Di Bonaventura, G; Pompilio, A; Verginelli, F | 1 |
Chong, SY; Chong, Y; Chung, HS; Hong, SG; Lee, K; Suh, Y | 1 |
Bayram, Y; Berktaş, M; Çıkman, A; Güdücüoğlu, H; Parlak, M | 1 |
Al-Hasan, MN; Ereshefsky, BJ; Gokun, Y; Martin, CA | 1 |
Chmura, A; Ciszek, M; Dobrzaniecka, K; Durlik, M; Kwiatkowski, A; Mlynarczyk, A; Mlynarczyk, G; Paczek, L; Sawicka-Grzelak, A; Szymanek-Majchrzak, K; Usarek, P | 1 |
Cho, SY; Chung, DR; Ha, YE; Kang, CI; Ko, JH; Lee, JY; Lee, NY; Lee, WJ; Park, GE; Peck, KR; Seok, HR; Song, JH | 1 |
Chatzikonstantinou, M; Galani, I; Margaritis, A; Petrikkos, G; Souli, M | 1 |
Abe, M; Araoka, H; Baba, M; Kimura, M; Okada, C; Yoneyama, A | 1 |
Bergallo, C; Cooper, CA; Dartois, N; Dukart, G; Gandjini, H; Jasovich, A; Mallick, R; Oliva, ME; Tanaseanu, C; Teglia, O | 1 |
Görümlü, G; Işikgoz Taşbakan, M; Karabulut, B; Pullukçu, H; Sanli, UA; Sipahi, OR; Tünger, A | 1 |
Gea-Banacloche, JC; Green, O; Murray, P | 1 |
Defife, R; Feinglass, JM; Postelnick, MJ; Scarsi, KK; Scheetz, MH | 1 |
Calenda, M; Franco, M; García, C; Passerini de Rossi, B; Vay, C | 1 |
Eames, T; Grabein, B; Kroth, J; Wollenberg, A | 1 |
Dien Bard, J; Humphries, R; Kelesidis, T; Lewinski, MA; Uslan, DZ; Ward, K | 1 |
Pea, F | 1 |
Calista, F; Fadda, G; Fiori, B; Mignogna, S; Romano, L; Sali, M; Spanu, T; Zappacosta, B | 1 |
Galvis, V; Rey, JJ; Tello, A; Villareal, D; Wong, CA | 1 |
Lemus-Peñaloza, J; Parra-Riffo, H | 1 |
Avison, MB; Gould, VC; Okazaki, A | 1 |
Ahn, JY; Chang, CL; Chong, Y; Chung, HS; Hong, SG; Kim, YR; Lee, HS; Lee, K; Park, YJ; Shin, JH; Shin, KS; Uh, Y; Whang, DH | 1 |
Critchley, IA; Evangelista, AT; Jones, ME; Karlowsky, JA; Noel, GJ; Sahm, DF; Thornsberry, C | 1 |
Chiang, SR; Chuang, YC; Ko, WC; Lee, HC; Tang, HJ; Wang, YY | 1 |
Gradon, JD; Smith, MD | 1 |
Hoepelman, I | 1 |
Bonfiglio, G; Lanzafame, A; Mattina, R; Santini, L | 1 |
Clarke, L; Elborn, JS; Goldsmith, CE; McCaughan, J; McKnight, AJ; Millar, BC; Moore, JE; Reid, A; Shaw, A | 1 |
Tash, K | 1 |
Barton, TD; Fishman, NO; Lautenbach, E; Quain, RD; Weiner, MG | 1 |
Chen, WH; Hsueh, PR; Luh, KT | 1 |
Blondeau, JM; Hansen, GT | 1 |
Anon, J; Kahn, J; Khashab, M; Paglia, M; Poole, M; Xiang, J | 1 |
Alvarez-Beltrán, M; Alvarez-Lerma, F; Grau, S | 1 |
Bassetti, M; Di Biagio, A; Fasce, R; Mannelli, S; Marchetti, F; Pallavicini, FB; Righi, E; Rosso, R; Viscoli, C | 1 |
Craig, M; Cumpston, AD; Devetten, MP; Ericson, SG; Hobbs, GR; Sarwari, AR | 1 |
Esposito, S; Ianniello, F; Leone, S; Noviello, S | 1 |
Chang, CY; Lee, YT; Liu, KS; Tsao, SM; Wang, YL | 1 |
Barry, AL; Fuchs, PC; Pfaller, MA | 1 |
Chow, AT; Fish, DN | 1 |
Furuya, N; Iwata, M; Matsumoto, T; Mizuiri, S; Tateda, K; Yamaguchi, K | 1 |
Dolmann, A; Fiss, E; Maesen, FP; Shah, PM; Vetter, N; Wesch, R | 1 |
Barry, AL; Brown, SD; Fuchs, PC | 1 |
Geddes, A; Härkönen, M; Jacobs, F; Nowotny, I; Schonwald, S; Thaler, M | 1 |
Bjarnason, J; Blondeau, JM; Laskowski, R; Stewart, C | 1 |
8 review(s) available for levofloxacin and Bacterial Infections, Gram-Negative
Article | Year |
---|---|
Early prosthetic endocarditis caused by Stenotrophomonas maltophilia.
Topics: Cardiac Surgical Procedures; Ceftazidime; Combined Modality Therapy; Device Removal; Drug Resistance, Multiple, Bacterial; Early Diagnosis; Endocarditis, Bacterial; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Middle Aged; Prosthesis-Related Infections; Stenotrophomonas maltophilia; Trimethoprim, Sulfamethoxazole Drug Combination | 2018 |
Roseomonas mucosa infective endocarditis in patient with systemic lupus erythematosus: case report and review of literature.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Bacteremia; Endocarditis; Endocarditis, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Lupus Erythematosus, Systemic; Methylobacteriaceae; Piperacillin, Tazobactam Drug Combination | 2019 |
[PK/PD profile and post-marketing surveillance of levofloxacin].
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Cohort Studies; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Kidney; Levofloxacin; Male; Metabolic Clearance Rate; Microbial Sensitivity Tests; Ofloxacin; Product Surveillance, Postmarketing; Respiratory Tract Infections; Spondylitis | 2009 |
Severe levofloxacin-induced hypoglycaemia: a case report and literature review.
Topics: Aged; Anti-Bacterial Agents; Catheter-Related Infections; Drug Therapy, Combination; Enterococcus; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Hypoglycemia; Immunocompromised Host; Kidney Failure, Chronic; Levofloxacin; Male; Ofloxacin; Renal Dialysis; Sepsis; Stenotrophomonas maltophilia; Trimethoprim, Sulfamethoxazole Drug Combination | 2012 |
Bacteremia due to Comamonas species possibly associated with exposure to tropical fish.
Topics: Administration, Oral; Aged; Aged, 80 and over; Animals; Animals, Domestic; Anti-Infective Agents; Bacteremia; Causality; Comamonas; Diagnosis, Differential; Drug Resistance; Environmental Exposure; Fever; Fish Diseases; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Ofloxacin; Pharyngitis; Tomography, X-Ray Computed; Treatment Outcome; Zoonoses | 2003 |
[New fluoroquinolones: levofloxacin, moxifloxacin and gatifloxacin].
Topics: Anti-Bacterial Agents; Aza Compounds; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Moxifloxacin; Ofloxacin; Pneumonia; Quinolines; Respiratory Tract Infections | 2004 |
Levofloxacin in the treatment of ventilator-associated pneumonia.
Topics: Anti-Infective Agents; Cross Infection; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Ofloxacin; Pneumonia, Bacterial; Respiration, Artificial | 2006 |
The clinical pharmacokinetics of levofloxacin.
Topics: Anti-Infective Agents; Clinical Trials, Phase III as Topic; Drug Interactions; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Ofloxacin | 1997 |
10 trial(s) available for levofloxacin and Bacterial Infections, Gram-Negative
Article | Year |
---|---|
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.
Topics: Anti-Bacterial Agents; Cephalosporins; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Skin Diseases, Bacterial; Staphylococcus | 2008 |
Incidence rate of fluoroquinolone-resistant gram-negative rod bacteremia among allogeneic hematopoietic cell transplantation patients during an era of levofloxacin prophylaxis.
Topics: Adult; Aged; Allografts; Anti-Bacterial Agents; Bacteremia; Drug Resistance, Bacterial; Female; Gram-Negative Anaerobic Straight, Curved, and Helical Rods; Gram-Negative Bacterial Infections; Humans; Incidence; Levofloxacin; Male; Middle Aged; Retrospective Studies; Time Factors | 2015 |
Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI).
Topics: Adult; Aged; Anti-Infective Agents, Urinary; Cephalosporins; Double-Blind Method; Drug Administration Schedule; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Levofloxacin; Male; Middle Aged; Penicillanic Acid; Pyelonephritis; Tazobactam; Treatment Outcome; Urinary Tract Infections; Young Adult | 2015 |
The Effectiveness of Prophylactic Antibiotics with Oral Levofloxacin against Post-Shock Wave Lithotripsy Infectious Complications: A Randomized Controlled Trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Drug Administration Schedule; Female; Follow-Up Studies; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Incidence; Levofloxacin; Lithotripsy; Male; Middle Aged; Treatment Outcome; Urinary Tract Infections; Young Adult | 2016 |
Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia.
Topics: Adult; Aged; Anti-Bacterial Agents; Community-Acquired Infections; Female; Gram-Negative Bacterial Infections; Haemophilus Infections; Humans; Levofloxacin; Liver Function Tests; Male; Middle Aged; Minocycline; Ofloxacin; Pneumococcal Infections; Pneumonia, Bacterial; Tigecycline; Treatment Outcome | 2008 |
A trial of high-dose, short-course levofloxacin for the treatment of acute bacterial sinusitis.
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Sinusitis; Treatment Outcome | 2006 |
Efficacy of the combination of levofloxacin plus ceftazidime in the treatment of hospital-acquired pneumonia in the intensive care unit.
Topics: Aged; Anti-Bacterial Agents; Ceftazidime; Cross Infection; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Italy; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Treatment Outcome | 2006 |
The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Levofloxacin; Male; Neutropenia; Ofloxacin; Retrospective Studies; Stem Cell Transplantation; Survival Analysis; Transplantation, Autologous; Transplantation, Homologous | 2007 |
Levofloxacin versus cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis: results of a randomized, double-blind study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Cefuroxime; Cephalosporins; Chronic Disease; Double-Blind Method; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Middle Aged; Ofloxacin; Treatment Outcome | 1999 |
Levofloxacin in the empirical treatment of patients with suspected bacteraemia/sepsis: comparison with imipenem/cilastatin in an open, randomized trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacteremia; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Levofloxacin; Middle Aged; Ofloxacin; Protease Inhibitors; Sepsis; Thienamycins | 1999 |
90 other study(ies) available for levofloxacin and Bacterial Infections, Gram-Negative
Article | Year |
---|---|
Antimicrobial susceptibilities and clinical sources of Dialister species.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Species Specificity; Veillonellaceae | 2007 |
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Canada; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance | 2008 |
Smqnr, a new chromosome-carried quinolone resistance gene in Stenotrophomonas maltophilia.
Topics: Alleles; Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; Chromosomes, Bacterial; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Fluoroquinolones; Genes, Bacterial; Gram-Negative Bacterial Infections; Humans; Molecular Sequence Data; Sequence Homology, Amino Acid; Stenotrophomonas maltophilia | 2008 |
First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.
Topics: Base Sequence; beta-Lactam Resistance; beta-Lactamases; Data Collection; DNA Primers; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Integrons; Italy; Molecular Epidemiology; Molecular Sequence Data | 2008 |
Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; China; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Imipenem; India; Klebsiella; Quinolones; Thailand | 2009 |
Assessment the efficacy of some various treatment methods, in vitro and in vivo, against Aeromonas hydrophila infection in fish with regard to side effects and residues.
Topics: Aeromonas hydrophila; Animal Feed; Animals; Anti-Bacterial Agents; Antioxidants; Aquaculture; Chitosan; Cichlids; Fish Diseases; Gram-Negative Bacterial Infections; Immunologic Factors; Levofloxacin; Microbial Sensitivity Tests; Nanoparticles; Oligosaccharides; Prebiotics; Survival Rate | 2022 |
Topics: Anti-Bacterial Agents; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Oxidative Stress; Stenotrophomonas maltophilia | 2022 |
Levofloxacin prophylaxis vs no prophylaxis in patients with neutropenia within an endemic country for carbapenem-resistant GNB.
Topics: Anti-Infective Agents; Carbapenems; Cohort Studies; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Neutropenia; Piperacillin; Retrospective Studies; Tazobactam; Transplantation, Homologous | 2023 |
Treatment, clinical outcomes, and predictors of mortality among a national cohort of hospitalized patients with Stenotrophomonas maltophilia infection.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Stenotrophomonas maltophilia; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2023 |
Appropriate antibiotic therapy is a predictor of outcome in patients with Stenotrophomonas maltophilia blood stream infection in the intensive care unit.
Topics: Anti-Bacterial Agents; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Levofloxacin; Retrospective Studies; Sepsis; Stenotrophomonas maltophilia; Trimethoprim, Sulfamethoxazole Drug Combination | 2023 |
In vitro susceptibilities of Stenotrophomonas maltophilia isolates to antimicrobial agents commonly used for related infections: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2004-2020.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Gram-Negative Bacterial Infections; Humans; Leadership; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Stenotrophomonas maltophilia; Tigecycline | 2023 |
Evaluation of phenotypical and genotypical methods for the identification and typing of Stenotrophomonas maltophilia isolated from a pharmaceutical facility.
Topics: Anti-Bacterial Agents; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Minocycline; RNA, Ribosomal, 16S; Stenotrophomonas maltophilia; Trimethoprim, Sulfamethoxazole Drug Combination | 2023 |
Clinical and Microbiologic Outcomes in Patients with Monomicrobial Stenotrophomonas maltophilia Infections.
Topics: Aged; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Stenotrophomonas maltophilia; Trimethoprim, Sulfamethoxazole Drug Combination | 2019 |
Levofloxacin-resistant Stenotrophomonas maltophilia: risk factors and antibiotic susceptibility patterns in hospitalized patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Ceftazidime; Colistin; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Hospitalization; Humans; Intensive Care Units; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Risk Factors; Stenotrophomonas maltophilia; Taiwan; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination | 2020 |
Stenotrophomonas maltophilia: An Emerging Pathogen of the Respiratory Tract.
Topics: Aged; Anti-Bacterial Agents; Fatal Outcome; Female; Gram-Negative Bacterial Infections; Heart Arrest; Humans; Levofloxacin; Opportunistic Infections; Pneumonia; Sepsis; Stenotrophomonas maltophilia; Trimethoprim, Sulfamethoxazole Drug Combination | 2020 |
Frequency and diversity of Stenotrophomonas spp. carrying bla
Topics: Anti-Bacterial Agents; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Stenotrophomonas; Stenotrophomonas maltophilia | 2020 |
Molecular epidemiology and risk factors of Stenotrophomonas maltophilia infections in a Chinese teaching hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Typing Techniques; Biofilms; Case-Control Studies; China; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Gene Expression; Genes, Bacterial; Gram-Negative Bacterial Infections; Hospitals, Teaching; Humans; Intensive Care Units; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Molecular Epidemiology; Multilocus Sequence Typing; Opportunistic Infections; Retrospective Studies; Risk Factors; Stenotrophomonas maltophilia; Trimethoprim, Sulfamethoxazole Drug Combination | 2020 |
Characteristics of gram-negative bacteremia during febrile neutropenia among allogeneic hematopoietic stem cell transplant recipients on levofloxacin prophylaxis.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Levofloxacin; Male; Middle Aged; Neutropenia; Retrospective Studies; Transplant Recipients; Young Adult | 2021 |
Emergence of concurrent levofloxacin- and trimethoprim/sulfamethoxazole-resistant Stenotrophomonas maltophilia: Risk factors and antimicrobial sensitivity pattern analysis from a single medical center in Taiwan.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Risk Factors; Stenotrophomonas maltophilia; Taiwan; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
Chromobacterium violaceum infection on lower limb skin: A case report.
Topics: Administration, Intravenous; Chromobacterium; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Lower Extremity; Male; Middle Aged; Opportunistic Infections; Piperacillin, Tazobactam Drug Combination; Skin; Skin Ulcer; Treatment Outcome | 2021 |
Sphingobacterium spiritivorum bacteremia due to cellulitis in an elderly man with chronic obstructive pulmonary disease and congestive heart failure: a case report.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Cellulitis; Gram-Negative Bacterial Infections; Heart Failure; Humans; Levofloxacin; Male; Meropenem; Pulmonary Disease, Chronic Obstructive; Shock, Septic; Sphingobacterium; Thienamycins; Treatment Outcome | 2017 |
Trauma Wound Related Infection Caused by Enterobacter cancerogenus and Aeromonas hydrophilia.
Topics: Aeromonas hydrophila; Aged, 80 and over; Anti-Bacterial Agents; Asian People; Enterobacter; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Meropenem; Thienamycins; Treatment Outcome; Wound Infection | 2018 |
Elizabethkingia miricola as an opportunistic oral pathogen associated with superinfectious complications in humoral immunodeficiency: a case report.
Topics: Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Complement C3a; Complement C5a; Female; Flavobacteriaceae; Gram-Negative Bacterial Infections; Humans; Immunity, Humoral; Immunoglobulin A; Immunoglobulins, Intravenous; Levofloxacin; Mouth; Periodontitis; RNA, Ribosomal, 16S; Saliva; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2017 |
Aeromonas enteritis: a great mimicker of acute appendicitis.
Topics: Aeromonas; Aged; Appendicitis; Diagnosis, Differential; Enteritis; Feces; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Tomography, X-Ray Computed | 2018 |
Clinical Features, Antibiotic Susceptibility Profile, and Outcomes of Infectious Keratitis Caused by Stenotrophomonas maltophilia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Corneal Ulcer; Eye Infections, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Polymyxin B; Retrospective Studies; Risk Factors; Stenotrophomonas maltophilia; Tobramycin; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2018 |
Topics: Aged; Anti-Bacterial Agents; Bronchoscopy; Empyema, Pleural; Foreign Bodies; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Lung; Male; Meropenem; Respiratory Aspiration; Sphingomonas; Thienamycins; Tomography, X-Ray Computed | 2018 |
Acute septic arthritis of shoulder joint caused by Aeromonas veronii biotype sobria.
Topics: Acute Disease; Aeromonas veronii; Aged, 80 and over; Arthritis, Infectious; Arthrocentesis; Cefoperazone; Female; Fever; Gram-Negative Bacterial Infections; Humans; Injections, Intravenous; Levofloxacin; Shoulder Joint; Tazobactam; Treatment Outcome | 2018 |
Nasal septal abscess caused by anaerobic bacteria of oral flora.
Topics: Abscess; Accidental Falls; Aged; Anti-Bacterial Agents; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Nasal Septum; Paracentesis; Peptostreptococcus; Tomography, X-Ray Computed; Tooth Socket; Veillonella | 2019 |
In vitro combination of tigecycline with other antibiotics in\
Stenotrophomonas maltophilia isolates
Topics: Anti-Infective Agents; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Stenotrophomonas maltophilia; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination | 2019 |
Falsely low ADAMTS13 activity caused by levofloxacin.
Topics: ADAMTS13 Protein; Adult; False Negative Reactions; Foot Ulcer; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Purpura, Thrombotic Thrombocytopenic; Stenotrophomonas | 2019 |
Clinical and histopathologic findings in cutaneous sting ray wounds: a case report.
Topics: Animals; Anti-Bacterial Agents; Bites and Stings; Gram-Negative Bacterial Infections; Granuloma; Humans; Leg; Levofloxacin; Male; Middle Aged; Skates, Fish; Skin Ulcer; Stenotrophomonas maltophilia; Wounds, Penetrating | 2013 |
Can levofloxacin be a useful alternative to trimethoprim-sulfamethoxazole for treating Stenotrophomonas maltophilia bacteremia?
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Female; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Stenotrophomonas maltophilia; Trimethoprim, Sulfamethoxazole Drug Combination | 2014 |
Risk factors for levofloxacin resistance in Stenotrophomonas maltophilia from respiratory tract in a regional hospital.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Female; Gram-Negative Bacterial Infections; Hospitals; Humans; Levofloxacin; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Respiratory Tract Infections; Risk Factors; Sputum; Stenotrophomonas maltophilia | 2015 |
Risk factors and outcomes of infections caused by extremely drug-resistant gram-negative bacilli in patients hospitalized in intensive care units.
Topics: Acinetobacter Infections; Adolescent; Age Factors; Aged; Amikacin; Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacterial Infections; Hospital Mortality; Humans; Immunocompromised Host; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Liver Diseases; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Time Factors | 2014 |
Fever of unknown origin in a young man.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Community-Acquired Infections; Fever; Fever of Unknown Origin; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Levofloxacin; Male; Sphingomonas | 2014 |
Clinical factors associated with acquisition of resistance to levofloxacin in Stenotrophomonas maltophilia.
Topics: Aged; Anti-Bacterial Agents; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Stenotrophomonas maltophilia | 2014 |
Prophylactic use of levofloxacin during medicinal leech therapy.
Topics: Adolescent; Adult; Aeromonas; Anti-Bacterial Agents; Antibiotic Prophylaxis; Child; Cost-Benefit Analysis; Female; Gram-Negative Bacterial Infections; Guideline Adherence; Humans; Leeching; Levofloxacin; Male; Middle Aged; Retrospective Studies; Young Adult | 2014 |
Stenotrophomonas maltophilia: rare cause of meningitis.
Topics: Anti-Bacterial Agents; Ceftazidime; Child, Preschool; Drug Combinations; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Meningitis, Bacterial; Stenotrophomonas maltophilia; Trimethoprim, Sulfamethoxazole Drug Combination | 2014 |
Stenotrophomonas maltophilia infection among young children in a cardiac intensive care unit: a single institution experience.
Topics: Anti-Bacterial Agents; Clavulanic Acids; Female; Gram-Negative Bacterial Infections; Humans; Incidence; Infant; Infant, Newborn; Intensive Care Units; Levofloxacin; Male; Retrospective Studies; Risk Factors; Stenotrophomonas maltophilia; Ticarcillin; Trimethoprim, Sulfamethoxazole Drug Combination | 2015 |
First human systemic infection caused by Spiroplasma.
Topics: Agammaglobulinemia; Aged; Anti-Bacterial Agents; Blood; DNA, Bacterial; Doxycycline; Female; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Microbiological Techniques; Molecular Sequence Data; Sepsis; Sequence Analysis, DNA; Spiroplasma; Treatment Outcome | 2015 |
Pelvic osteomyelitis presenting as groin and medial thigh pain: a resident's case problem.
Topics: Aged; Anti-Bacterial Agents; Diagnosis, Differential; Gram-Negative Bacterial Infections; Groin; Humans; Levofloxacin; Male; Muscle Weakness; Myositis; Obturator Nerve; Osteomyelitis; Pain; Paralysis; Pelvic Bones; Stenotrophomonas maltophilia; Thigh | 2015 |
Microbial keratitis in los angeles: the doheny eye institute and the los angeles county hospital experience.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Child; Ciprofloxacin; Corneal Ulcer; Eye Infections, Bacterial; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hospitals, County; Humans; Levofloxacin; Los Angeles; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies | 2015 |
Microbiological and clinical features of four cases of catheter-related infection by Methylobacterium radiotolerans.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Catheter-Related Infections; Child; Ciprofloxacin; Female; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Methylobacterium; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Young Adult | 2015 |
[Investigation of the presence of class 1, 2, 3 integrons and their relationships with antibiotic resistance in clinical Stenotrophomonas maltophilia isolates].
Topics: Anti-Infective Agents; Ceftazidime; Chloramphenicol; Communicable Diseases, Emerging; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Integrons; Levofloxacin; Opportunistic Infections; Plasmids; Stenotrophomonas maltophilia; Trimethoprim, Sulfamethoxazole Drug Combination | 2015 |
Distribution of Class 1 Integrons, sul1 and sul2 Genes Among Clinical Isolates of Stenotrophomonas maltophilia from a Tertiary Care Hospital in North India.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; India; Integrons; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Molecular Typing; Polymerase Chain Reaction; Stenotrophomonas maltophilia; Tertiary Care Centers; Trimethoprim, Sulfamethoxazole Drug Combination | 2015 |
Spondylodiscitis due to Rhizobium radiobacter.
Topics: Aged, 80 and over; Agrobacterium tumefaciens; Anti-Bacterial Agents; Bacteremia; C-Reactive Protein; Catheter-Related Infections; Catheterization, Central Venous; Discitis; Drug Resistance, Multiple, Bacterial; Environmental Exposure; Female; Gram-Negative Bacterial Infections; Heart Failure; Humans; Immunocompromised Host; Levofloxacin; Lumbar Vertebrae; Lymphoma, Follicular; Rituximab; Tomography, X-Ray Computed | 2015 |
A new ASPECT for complicated urinary tract infections.
Topics: Anti-Infective Agents, Urinary; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Penicillanic Acid; Urinary Tract Infections | 2015 |
Infection: Ceftolozane-tazobactam gives a new ASPECT to the fight against antimicrobial resistance.
Topics: Anti-Infective Agents, Urinary; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Penicillanic Acid; Urinary Tract Infections | 2015 |
A Monte Carlo pharmacokinetic/pharmacodynamic simulation to evaluate the efficacy of minocycline, tigecycline, moxifloxacin, and levofloxacin in the treatment of hospital-acquired pneumonia caused by Stenotrophomonas maltophilia.
Topics: Adult; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Cross Infection; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Minocycline; Monte Carlo Method; Moxifloxacin; Pneumonia; Sputum; Stenotrophomonas maltophilia; Tigecycline | 2015 |
[Comparative study on the usefulness of antibacterial prophylaxis with levofloxacin in patients submitted to hematopoietic stem cell transplantation].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Female; Gram-Negative Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Levofloxacin; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Young Adult | 2016 |
Ceftolozane-tazobactam versus levofloxacin in urinary tract infection.
Topics: Anti-Infective Agents, Urinary; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Penicillanic Acid; Urinary Tract Infections | 2015 |
Ceftolozane-tazobactam versus levofloxacin in urinary tract infection.
Topics: Anti-Infective Agents, Urinary; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Penicillanic Acid; Urinary Tract Infections | 2015 |
Ceftolozane-tazobactam versus levofloxacin in urinary tract infection.
Topics: Anti-Infective Agents, Urinary; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Penicillanic Acid; Urinary Tract Infections | 2015 |
Ceftolozane-tazobactam versus levofloxacin in urinary tract infection - Authors' reply.
Topics: Anti-Infective Agents, Urinary; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Penicillanic Acid; Urinary Tract Infections | 2015 |
Effect of High-Dose Antimicrobials on Biofilm Growth of Achromobacter Species Isolated from Cystic Fibrosis Patients.
Topics: Achromobacter; Amikacin; Anti-Bacterial Agents; Aztreonam; Biofilms; Colistin; Cystic Fibrosis; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Plankton; Tobramycin | 2016 |
Antibiotic susceptibility of sulfamethoxazole-trimethoprim resistant Stenotrophomonas maltophilia strains isolated at a tertiary care centre in Hungary.
Topics: Anti-Bacterial Agents; Ceftazidime; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Hungary; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Stenotrophomonas maltophilia; Tertiary Care Centers; Tigecycline | 2015 |
Isolation and Characterization of Stenotrophomonas maltophilia Isolates from a Brazilian Hospital.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Biofilms; Brazil; Ceftazidime; Chloramphenicol; Cross Infection; Drug Resistance, Bacterial; Fomites; Gene Expression Regulation, Bacterial; Genes, Bacterial; Gram-Negative Bacterial Infections; Hospitals; Humans; Integrons; Levofloxacin; Minocycline; Phylogeny; Plasmids; Polymerase Chain Reaction; Stenotrophomonas maltophilia; Trimethoprim, Sulfamethoxazole Drug Combination | 2016 |
Characteristics comparisons of bacteremia in allogeneic and autologous hematopoietic stem cell-transplant recipients with levofloxacin prophylaxis and influence on resistant bacteria emergence.
Topics: Adolescent; Adult; Aged; Antibiotic Prophylaxis; Bacteremia; Drug Resistance, Multiple, Bacterial; Female; Graft vs Host Disease; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Levofloxacin; Male; Middle Aged; Retrospective Studies; Risk Factors; Taiwan; Transplant Recipients; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome; Young Adult | 2018 |
In vitro activity of levofloxacin against planktonic and biofilm Stenotrophomonas maltophilia lifestyles under conditions relevant to pulmonary infection in cystic fibrosis, and relationship with SmeDEF multidrug efflux pump expression.
Topics: Anti-Bacterial Agents; Biofilms; Cystic Fibrosis; Gene Expression Regulation, Bacterial; Genes, MDR; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Pneumonia, Bacterial; Stenotrophomonas maltophilia | 2016 |
Levofloxacin Efflux and smeD in Clinical Isolates of Stenotrophomonas maltophilia.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ceftazidime; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Membrane Transport Proteins; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Stenotrophomonas maltophilia; Ticarcillin; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination | 2017 |
Antibiotics resistance of Stenotrophomonas maltophilia strains isolated from various clinical specimens.
Topics: Anti-Bacterial Agents; Ceftazidime; Chloramphenicol; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Stenotrophomonas maltophilia; Trimethoprim, Sulfamethoxazole Drug Combination; Turkey | 2016 |
Comparison of ß-lactam plus aminoglycoside versus ß-lactam plus fluoroquinolone empirical therapy in serious nosocomial infections due to Gram-negative bacilli.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Cohort Studies; Critical Illness; Cross Infection; Drug Therapy, Combination; Female; Fluoroquinolones; Gentamicins; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Proportional Hazards Models; Retrospective Studies; Tobramycin; Treatment Outcome | 2017 |
Drug Susceptibility Assessment in Stenotrophomonas Maltophilia Strains Isolated From the Blood of Organ Transplantation Recipients in a Warsaw Teaching Hospital During 2011 to 2014.
Topics: Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Clavulanic Acids; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Hospitals, Teaching; Humans; Levofloxacin; Microbial Sensitivity Tests; Organ Transplantation; Stenotrophomonas maltophilia; Ticarcillin; Transplant Recipients; Trimethoprim, Sulfamethoxazole Drug Combination | 2016 |
Clinical Features and Risk Factors for Development of Breakthrough Gram-Negative Bacteremia during Carbapenem Therapy.
Topics: Acinetobacter baumannii; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Cross Infection; Female; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Intensive Care Units; Length of Stay; Levofloxacin; Male; Middle Aged; Neutropenia; Pseudomonas aeruginosa; Respiratory Tract Infections; Risk Factors; Stenotrophomonas maltophilia; Survival Analysis; Tertiary Care Centers; Trimethoprim, Sulfamethoxazole Drug Combination | 2016 |
Plasmid-mediated quinolone resistance determinants among Gram-negative bacteraemia isolates: a hidden threat.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Gram-Negative Bacterial Infections; Greece; Humans; Levofloxacin; Microbial Sensitivity Tests; Mutation; Quinolones; R Factors; Stenotrophomonas maltophilia | 2017 |
Evaluation of trimethoprim-sulfamethoxazole based combination therapy against Stenotrophomonas maltophilia: in vitro effects and clinical efficacy in cancer patients.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Clavulanic Acids; Drug Therapy, Combination; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Middle Aged; Minocycline; Neoplasms; Stenotrophomonas maltophilia; Ticarcillin; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2017 |
[A rare cause of catheter-related bacteremia: Rhizobium radiobacter].
Topics: Adult; Agrobacterium tumefaciens; Anti-Bacterial Agents; Bacteremia; Bone Neoplasms; Catheterization, Central Venous; Catheters, Indwelling; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Levofloxacin; Male; Microbial Sensitivity Tests; Ofloxacin; Osteosarcoma | 2008 |
Sepsis caused by Elizabethkingia miricola successfully treated with tigecycline and levofloxacin.
Topics: Anti-Bacterial Agents; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Lymphoma, Mantle-Cell; Male; Middle Aged; Minocycline; Ofloxacin; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Sepsis; Stem Cell Transplantation; Tigecycline | 2008 |
Effect of differences in MIC values on clinical outcomes in patients with bloodstream infections caused by gram-negative organisms treated with levofloxacin.
Topics: Adult; Aged; Anti-Bacterial Agents; Cohort Studies; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Length of Stay; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Retrospective Studies; Treatment Outcome | 2009 |
Activity of levofloxacin and ciprofloxacin on biofilms and planktonic cells of Stenotrophomonas maltophilia isolates from patients with device-associated infections.
Topics: Anti-Infective Agents; Argentina; Biofilms; Ciprofloxacin; Cross Infection; Drug Resistance, Multiple, Bacterial; Equipment Contamination; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Stenotrophomonas maltophilia | 2009 |
Microbiological analysis of epidermal growth factor receptor inhibitor therapy-associated paronychia.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cephalosporins; Cetuximab; Ciprofloxacin; ErbB Receptors; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Ofloxacin; Paronychia; Retrospective Studies; Skin | 2010 |
First report of treatment of Anaerobiospirillum succiniciproducens bloodstream infection with levofloxacin.
Topics: Aged, 80 and over; Anaerobiospirillum; Anti-Bacterial Agents; Bacteremia; DNA, Bacterial; DNA, Ribosomal; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Microscopy; Microscopy, Electron, Transmission; Ofloxacin; RNA, Ribosomal, 16S; Sequence Analysis, DNA | 2010 |
Tsukamurella tyrosinosolvens and Rhizobium radiobacter sepsis presenting with septic pulmonary emboli.
Topics: Actinomycetales; Actinomycetales Infections; Aged; Agrobacterium tumefaciens; Anti-Bacterial Agents; Catheter-Related Infections; Catheterization, Central Venous; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Ofloxacin; Pulmonary Embolism; Radiography, Thoracic; Sepsis; Tomography, X-Ray Computed | 2011 |
[In vitro antibiotic susceptibility to fluoroquinolones].
Topics: Acanthamoeba Keratitis; Anti-Bacterial Agents; Aza Compounds; Body Fluids; Ciprofloxacin; Colombia; Conjunctivitis, Bacterial; Drug Resistance, Multiple, Bacterial; Eye Infections, Bacterial; Eye Infections, Fungal; Eye Infections, Parasitic; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Keratitis; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Retrospective Studies | 2012 |
Coordinate hyperproduction of SmeZ and SmeJK efflux pumps extends drug resistance in Stenotrophomonas maltophilia.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Ciprofloxacin; Gene Expression; Genes, MDR; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Membrane Transport Proteins; Microbial Sensitivity Tests; Minocycline; Ofloxacin; Stenotrophomonas maltophilia; Tetracycline | 2013 |
Antimicrobial susceptibility of stenotrophomonas maltophilia isolates from Korea, and the activity of antimicrobial combinations against the isolates.
Topics: Anti-Infective Agents; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Ofloxacin; Republic of Korea; Stenotrophomonas maltophilia; Trimethoprim, Sulfamethoxazole Drug Combination | 2013 |
Susceptibilities to levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis clinical isolates from children: results from 2000-2001 and 2001-2002 TRUST studies in the United States.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Azithromycin; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Lactams; Levofloxacin; Microbial Sensitivity Tests; Middle Aged; Moraxella catarrhalis; Ofloxacin; Pneumococcal Infections; Prospective Studies; Respiratory Tract Infections; Streptococcus pneumoniae; Trimethoprim, Sulfamethoxazole Drug Combination; United States | 2003 |
In vitro and in vivo activities of fluoroquinolones against Aeromonas hydrophila.
Topics: Aeromonas hydrophila; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Cefotaxime; Ciprofloxacin; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacterial Infections; Humans; In Vitro Techniques; Levofloxacin; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Ofloxacin; Quinolines; Quinolones | 2003 |
In vitro activity of levofloxacin against recent Gram-negative nosocomial pathogens.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin | 2005 |
Comparison of in vitro susceptibilities to levofloxacin and ciprofloxacin with Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolated from cystic fibrosis patients in Northern Ireland.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Child; Ciprofloxacin; Cystic Fibrosis; Female; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Stenotrophomonas maltophilia | 2005 |
Rahnella aquatilis bacteremia from a suspected urinary source.
Topics: Aged; Anti-Bacterial Agents; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Levofloxacin; Male; Microbial Sensitivity Tests; Ofloxacin; Prostatic Hyperplasia; Pyelonephritis; Rahnella | 2005 |
Coadministration of oral levofloxacin with agents that impair its absorption: potential impact on emergence of resistance.
Topics: Administration, Oral; Adsorption; Aged; Anti-Bacterial Agents; Case-Control Studies; Cations, Divalent; Drug Interactions; Drug Resistance, Bacterial; Drug Therapy, Combination; Elements; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Staphylococcal Infections; Staphylococcus; Time Factors | 2005 |
Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Incidence; Length of Stay; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Taiwan | 2005 |
Comparison of the minimum inhibitory, mutant prevention and minimum bactericidal concentrations of ciprofloxacin, levofloxacin and garenoxacin against enteric Gram-negative urinary tract infection pathogens.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Mutation; Ofloxacin; Urinary Tract Infections | 2005 |
[In vitro activity of prulifloxacin, levofloxacin and ciprofloxacin against urinary pathogens].
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dioxolanes; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Piperazines; Quinolones; Staphylococcus aureus; Urinary Tract Infections | 2006 |
Chromobacterium violaceum infection in Taiwan: a case report and literature review.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Chromobacterium; Female; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Ofloxacin; Taiwan; Wound Infection | 2007 |
Levofloxacin disk potency and tentative interpretive criteria for susceptibility tests.
Topics: Evaluation Studies as Topic; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin | 1993 |
Primary Shewanella alga septicemia in a patient on hemodialysis.
Topics: Anti-Bacterial Agents; Bacteremia; Cefazolin; Drug Therapy, Combination; Escherichia coli; Female; Gentamicins; Gram-Negative Bacterial Infections; Gram-Negative Facultatively Anaerobic Rods; Humans; Levofloxacin; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Renal Dialysis | 1999 |
Antibacterial activity of moxifloxacin (Bay 12-8039) against aerobic clinical isolates, and provisional criteria for disk susceptibility tests.
Topics: Anti-Infective Agents; Aza Compounds; Bacteria, Aerobic; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines | 1999 |
Comparative in vitro activity of gatifloxacin, grepafloxacin, levofloxacin, moxifloxacin and trovafloxacin against 4151 Gram-negative and Gram-positive organisms.
Topics: Anti-Infective Agents; Aza Compounds; Drug Resistance, Microbial; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Piperazines; Quinolines | 2000 |